# Expanding the Pool in Orthotopic Heart Transplantation

> **NCT03222531** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Mary E. Keebler, MD** · enrollment: 20 (estimated)

## Conditions studied

- Hepatitis C
- Heart Transplant
- Cardiac Transplant

## Interventions

- **DRUG:** sofosbuvir/velpatasvir

## Key facts

- **NCT ID:** NCT03222531
- **Lead sponsor:** Mary E. Keebler, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-08-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03222531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03222531, "Expanding the Pool in Orthotopic Heart Transplantation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03222531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*